**Use Your Power for Purpose** Pfizer’s pediatric pneumococcal vaccine, Prevnar 20, was approved by the FDA in April 2023 and received its ACIP recommendation in June 2023. This vaccine expands serotype coverage to 20 and aims to further protect children from serious pneumococcal disease. This next generation vaccine is a “blockbuster” for the U.S. and […]
